Page last updated: 2024-08-16

proadifen and mitoxantrone

proadifen has been researched along with mitoxantrone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fedoročko, P; Hiľovská, L; Jendželovská, Z; Jendželovský, R; Kovaľ, J	1

Other Studies

1 other study(ies) available for proadifen and mitoxantrone

Article	Year
Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells. International journal of oncology, 2015, Volume: 47, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Mitoxantrone; Proadifen; Reverse Transcriptase Polymerase Chain Reaction	2015

Article

Year

Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells.

International journal of oncology, 2015, Volume: 47, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Mitoxantrone; Proadifen; Reverse Transcriptase Polymerase Chain Reaction

2015